Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study

Summary

Due to Quetiapine's particulars and the promising receptor profile, we want to examine the efficacy concerning relapse prevention of alcoholics suffering from persisting craving and/or affective symptoms (persisting sleep disorder, persisting excitement, persisting depressive symptoms, persisting anxiety symptoms) in comparison to matching placebo in a double-blind pilot study. We further want to compare the course of the above mentioned craving and affective symptoms under medication with quetiapine / matching placebo.

Timeline

Start

2007-11

Primary completion

2009-08

Completion

2010-02

Drugs

Indications